Text by Kendall Powell kendall2@nasw.org Walking a fine caspase line W hether caspase enzymes perform developmental tasks or cause cell death can depend on the timing with which a caspase inhibitor protein turns over, fi nd Koto et al. They show that the inhibitor protein follows a dramatic temporal regulation specifi c to cell type and maturity. In the last decade, researchers realized that the destructive capabilities of caspase enzymes can be harnessed to carry out certain developmental events, such as dendrite pruning and sperm individualization. But how the caspases are put to work in these scenarios without turning deadly remains a mystery.
Koto et al. devised a fl uorescent version of the caspase inhibitor DIAP1 to follow its fate in live Drosophila cells during sensory organ bristle development. Surprisingly, the inhibitor vanished altogether in the midst of cell differentiation, without activating cell death, and then reappeared in two cells, including the shaft cell, which spurts forth the bristle. An excess of DIAP1 in the shaft cell gave shorter, thicker bristles, whereas knocking down diap1 resulted in the loss of the shaft cell to programmed cell death. DIAP1's timely reappearance in this cell followed by a second quick departure appears to ensure the delicate balance between caspase-driven bristle formation and the cell death cascade. The nonlethal nature of the DIAP1 disappearances in these cells indicates other survival strategies exist.
The researchers propose that DIAP1's degradation promotes activation of the initiator caspase, Dronc, without waking up the downstream executioner caspases. Whereas other studies have shown non-death caspase activities sequestered to subcellular compartments, this work hints that caspases can also be activated just a touch, before being turned back down. Koto, A., et al. 2009 . J. Cell Biol. doi:10.1083 .
Securing the next generation's peroxisomes
T he same protein that directs the biogenesis of peroxisomes, essential detoxifi ers of the cell, also hitches the organelle to its myosin motor for transport into daughter cells, show Chang et al.
The beloved model Saccharomyces cerevisiae does have limitations-one being that its peroxisome receptor for the myosin V motor has no known homologues outside of this fungus family. To fi gure out how other eukaryotes accomplish peroxisome inheritance, Chang et al. turned to the yeast Yarrowia lipolytica and a new player, Pex3B.
Pex3B was recently identifi ed as a paralogue of Pex3, the highly conserved protein responsible for the earliest stages of peroxisome genesis-forming new membrane at the ER.
Chang et al. found that, like Pex3, Pex3B is a peroxisomal integral membrane protein. Deleting Pex3B resulted in long, tubular peroxisomes, which were conspicuously absent from the bud tips of dividing cells. Closer inspection of inheritance in pex3BΔ cells revealed that the organelles had trouble entering the bud and, once there, ceased moving altogether, with the stretched peroxisomes often straddling the mother-bud neck.
These movement troubles hinted at a role for Pex3B as the organelle's myosin V receptor. Not only did Pex3B bind to the motor, but the team showed that Pex3 did as well. In fact, when overexpressed, Pex3 compensated for the inheritance defect of the pex3BΔ cells. Pex3's paralogue allowed Chang et al. to uncover its hidden talent as a myosin receptor, which establishes a direct temporal link between biogenesis and transfer. The authors propose Pex3's dual activities ensure that new, fresh peroxisomes move into new cells, while old, oxidatively damaged organelles remain behind. Chang, J., et al. 2009 . J. Cell Biol. doi:10.1083 Deleting Pex3B, a paralogue of Pex3, causes stretched, tubular peroxisomes (green) and inheritance defects.
PIKfyve promotes neuron self-preser vation T suruta et al. fi nd that a lipid kinase directs a voltage-gated calcium channel's degradation to save neurons from a lethal dose of overexcitement.
An important player in cellular signaling, calcium is also terribly toxic at high levels. Neurons have evolved ways to protect themselves against the calcium infl uxes that come during periods of intense electrical activity. One way to limit the calcium fl ood is to remove the gatekeepers, calcium channels, from the cell surface. How neurons direct this is clinically important in a range of disorders from stroke to Alzheimer's disease.
In a proteomic screen for binding partners of the Ca V 1.2 channel, Tsuruta et al. extracted what seemed a strange companion at fi rst: PIKfyve, the lipid kinase that generates PtdIns(3,5)P 2 and promotes the maturation of endosomes into lysosomes. Other groups had recently shown that mutations affecting PtdIns(3,5)P 2 production cause degeneration of excitable cells in both mice and humans, including mutants found in ALS and Charcot-Marie-Tooth disease. The team hypothesized that PIKfyve might be directing Ca V 1.2 degradation. Using glutamate excitation to simulate excitotoxic stress, the authors showed that Ca V 1.2 is internalized, associates with PIKfyve, and is degraded in the lysosome. When Tsuruta et al. squelched levels of PIKfyve or PtdIns(3,5)P 2 , excess channels stayed at the surface and left neurons vulnerable to apoptosis.
The fi ndings clarify how this neuroprotective mechanism unfolds and suggest that existing calcium channel-blocking drugs might aid patients with neurodegenerative disorders stemming from a PtdIns(3,5)P 2 defect. 
